Vyteris Company Profile
Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company ("BD"). Becton Dickinson created Transdermal Systems just prior to 1990 and invested 10 years in the technology Headquartered in Fair Lawn, New Jersey, Vyteris occupies 27,000 square feet of space devoted to research, development and manufacturing of transdermal medication delivery products.
We have a portfolio of over 60 U.S. patents and over 65 international patents issued, with an additional 45 patents filed.
13-01 Pollitt Drive
United States of America
Drugs and Medications
Vyteris, Inc. is the maker of the first active, ready-to-use drug delivery patch (LidoSiteÂ®) to receive marketing clearance from the U.S. Food and Drug Administration. Vyteris'...
Vyteris was organized in November 2000 as a spinout of the Transdermal Systems unit of Becton Dickinson and Company ("BD"). Becton Dickinson created Transdermal Systems just prior to 1990 and invested...
More Information about "Vyteris" on BioPortfolio
We have published hundreds of Vyteris news stories on BioPortfolio along with dozens of Vyteris Clinical Trials and PubMed Articles about Vyteris for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Vyteris Companies in our database. You can also find out about relevant Vyteris Drugs and Medications on this site too.